01.12.2012 Views

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

during the testing procedure. I had demonstrated that it was possible to measure exhaled NO<br />

in children, both healthy controls and asthmatics. In fact in some <strong>of</strong> the control children, they<br />

found the exhaled NO measurements an easier task than completing lung function testing to<br />

ATS criteria standards. I had demonstrated significantly higher levels <strong>of</strong> exhaled NO was<br />

found in children with asthma on bronchodilator therapy only when compared to healthy<br />

children and asthmatics on regular IHCS therapy, with no difference between the latter two<br />

groups. Finally I had also demonstrated in a small group <strong>of</strong> asthmatic children the exhaled NO<br />

levels reduced significantly following two weeks <strong>of</strong> IHCS treatment' <strong>The</strong>se findings<br />

contributed to the evolving literature to suggest that NO was a marker for ainvay<br />

inflammation in asthma. I was invited with other research groups working in this area to<br />

present this data to a European Society Task Force (ESTF) meeting in Stockholm in<br />

September 1996 as a satellite working party to the European Respiratory Society Annual<br />

Conference where the first discussion regarding standardisation procedures took place. This<br />

later became the basis for the first publication setting out the best standard practices based on<br />

the data available (Kharitonov, Alving et al. 1997)'<br />

In the following chapter I will review how research in exhaled No and nasal No<br />

measurement has progressed. I will review the findings on factors that altered No results in<br />

both healthy groups and those with respiratory diseases. I will show how the standardisation<br />

procedure for testing has continued to evolve to the present day. I will then review the<br />

findings in the literature across adults, children and infants with a variety <strong>of</strong> conditions. I will<br />

end with an opinion as to the best use <strong>of</strong> exhaled and nasal NO testing is at the current time'<br />

<strong>The</strong> work in this chapterformed the basis <strong>of</strong> the publications:<br />

o Dinarevic S, Byrnes CA, Bush A, Shinebourne EA' Measurement <strong>of</strong> expired nitric<br />

oxide levels in child.ren. Pediatric Pulmonology 1996; 22: 396-401<br />

. Byrnes CA, Dinarevic s, shineboume EA, Barnes PJ, Bush A' ExhAled No<br />

measurements in normal and asthmatic child,ren. Pediatric Pulmonology 1997; 24:<br />

312-318<br />

20t

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!